SAPA 14th Annual Conference
Program
Opportunities
& Challenge:
Pharmaceutical
and Biotechnology Innovation and Globalization
August 18-20, 2006
Charles Wang, Ph.D., SAPA
President-Elect & Conference Co-Chair
Xiaohui Mei, Ph.D., Conference
General Secretary
Friday, August 18
1:30 – 5:30 pm
“IND Filling: Basic
requirements and strategy”
Lecture/Tutorial
and Interactive Session
In this workshop, there will be professionals in the field to provide a tutorial and lectures on how to successfully open an IND and avoid the most common mistakes. Real case studies will be examined and discussed.
“Non-clinically Successful Filing of INDs”
Dr. Luqi Pei
Sr. Pharmacologist/Toxicologist
CDER, FDA
“ADME Requirements and strategies for IND filing”
Dr. Handan He
Associate Director, Head of ADME
Novartis Pharmaceuticals Inc.
“CMC Requirements and strategies for IND filing”
Dr. Sherry Ku
Sr. Director of Pharmaceutical
Science
Wyeth
“Clinical considerations of IND filing”
Dr. Simon Li
Vise-President of Medical Research
Neuromed Pharmaceuticals
Inc.
Speaker and Sponsor Reception
Friday,
August 18, 6:30 – 9:30 pm
Location
TBD
Saturday, August 19
Busch Campus Center, Rutgers
University, Piscataway, NJ 08854
Registration and Breakfast - 7:30am to 8:30am
Plenary Session
8:30 am to 12:30 pm
Chair:
Dr. Yusheng Wu
Keynote Speakers:
Dr. Lee Babiss,
VP, Hoffmann-La Roche (confirmed)
“Metabolic Syndrome and
Endoconnahwird System”
Dr. Paul Chew, VP, Sanofi-Aventis (confirmed)
Dr. Mauricio Futran, VP, BMS (invited)
Dr. Herman Van Cauteren, Sr. VP J&JPRD (confirmed)
"Innovative Drug Discovery in
China: Mission Possible?"
Dr. En Li, Vice President and Global
Head of Models of
Disease Center, Novartis Institutes for BioMedical
Research (Invited)
Opening Remark:
Afternoon Session - 1:30 pm to 5:30 pm
“Talk Title-TBD”
Mr. Zegong Zhang
Vice Director
Beijing Pharma &
Biotech Center (BPBC)
“Talk Title-TBD”
Dr. Li Chen
CSO
Roche R&D China
“The world is flat-R&D outsourcing in China”
Dr.
Ge Li
CEO
Wuxi
Pharmatech
“Pharmaceutical brand communication”
Mr.
Tony Y. Zhang
Managing
Partner
BizPro
International
“Talk Title-TBD”
Mr.
Kewen Jin
CEO
Shanghai
BioExplorer
“Talk Title-TBD”
Ms.
Maggie Wang
General
Manager
Zhejinag
Lianhe Chemical Technology
“Talk Title-TBD”
Mr.
Hai Wang
VP
Zhejinag Huahai
Career Development
Chairs:
Drs. Gen Li & Bill Wei
“Talk Title-TBD”
Dr.
Ge Li
CEO
Wuxi
Pharmatech
“Talk Title-TBD”
Dr. Xu Bibo
Analytical lab (Invited)
“Talk Title-TBD”
Dr. Xiongwei Shi
CEO
Shanghai United Pharmatech
“Talk Title-TBD”
Jin Wang
Manhattan Capital
“Talk Title-TBD”
Janet Leduox
Director, Human Resource
J&JPRD
“Health Benefits of Antioxidants and
Balanced Foods for Chronic Disease Prevention”
Rui Hai Liu, M.D., Ph.D.
Associate Professor
Cornell University
“Nanotechnology in Functional Foods
Research”
Qingrong Huang, Ph.D
Assistant Professor
Rutgers, The State University of New Jersey
“Talk Title-TBD”
Qunyi Zheng, Ph.D
President
Kent Financial Services
Banquet
7:00 PM-9:30 PM
Sunday, August 20
Busch Campus Center, Rutgers
University, Piscataway, NJ 08854
Chairs: Drs. Min Li & Jianji Wang
“The successful story
of the returnees”
(English/Chinese Speaking)
1:30 am to 5:30 pm
“Talk Title-TBD”
Dr. Xiongwei Shi
CEO
Shanghai United Pharmatech
“Talk Title-TBD”
Mr. Kechun Li
General Manager
Chiral Quest China
“Talk Title-TBD”
Jin
Wang
Manhattan
Capital
“Talk Title-TBD”
Dr. Guohua Zhang (invited)
Senior VP
Andrx Pharmaceuticals
“Talk Title-TBD”
Mr. Ye Liu
VP
Beijing Bioengineering & Pharmaceutical Industrial park
“Talk Title-TBD”
Dr. Jason Gang Jin
President
MaxyBio Corporation
“Talk Title-TBD”
Dr.
Don Qiu
CEO
Beijing
Joinn Pharmaceutical Center
“Talk Title-TBD”
Mr. Pau Guo (CEO)/Mr. Bin Yu
VP
Astatech
“Talk Title-TBD”
Dr. Julie Jia
Drug Discovery Specialist
Millipore
“The pharmaceutical industry and pharmaceutical market status
of China”
Ms. Huifang Wu
Vice General Manager
Beijing Orientbit Technology
“Talk Title-TBD”
Dr.
Jin Ren
Director,
Drug Safety Evaluation Center
Shanghai
Institute of Materia Medica, CAS